XML 48 R38.htm IDEA: XBRL DOCUMENT
v3.25.2

Stockholders' Equity (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Equity [Abstract] |
Schedule of Equity Compensation Goals | The three independent vesting conditions are described in the following table:
|  | Operational Goals(1) (in millions) |  | Stock Price Goal |  |  | Minimum Service Requirement |  |
Tranche(2) |  | Revenue |  | Adj. EBITDA(3) |  |  |  | 2024 Employee XSP |  | 2024 CEO Performance Award |  | Goal Expiration
1 |  | $ | 1,834 |  | or | $ | 382 |  | and | $ | 247.40 |  | and |  | June 2025 |  | December 2028 |  | December 31, 2026
2 |  | 2,293 |  | or | 497 |  | and | 309.25 |  | and |  | December 2025 |  | December 2028 |  | December 31, 2027
3 |  | 2,866 |  | or | 622 |  | and | 386.56 |  | and |  | June 2026 |  | December 2029 |  | December 31, 2028
4 |  | 3,583 |  | or | 812 |  | and | 483.20 |  | and |  | December 2026 |  | December 2029 |  | December 31, 2029
5 |  | 4,479 |  | or | 1,055 |  | and | 604.00 |  | and |  | June 2027 |  | December 2030 |  | December 31, 2030
6 |  | 5,599 |  | or | 1,367 |  | and | 755.00 |  | and |  | December 2027 |  | December 2030 |  | December 31, 2031
7 |  | 6,999 |  | or | 1,717 |  | and | 943.75 |  | and |  | June 2028 |  | December 2030 |  | December 31, 2032
(1) Operational goals are measured, as of any date, for the previous four consecutive fiscal quarters, beginning with the Company's first full fiscal quarter ending after the fiscal quarter in which the grant date occurred. (2) Tranche 1 vested and settled in June 2025. For certain grantees, the shares acquired upon vesting and settlement of Tranche 1 are subject to a holding period requirement under the plan, which will expire on the earlier of (i) December 31, 2030 and (ii) the date on which the subsequent tranche vests and settles. (3) In connection with certain acquisitions which were completed during fiscal year 2024, the adjusted EBITDA goals were adjusted as required by the terms of the 2024 Employee XSP and 2024 CEO Performance Award. As the operational goals for Tranches 1 and 2 were met as of December 31, 2024, no further adjustment to the adjusted EBITDA goals for these tranches was made in the current period, in accordance with the terms of the awards.
Schedule of Restricted Stock Unit Activity | The following table summarizes restricted stock unit (“RSU”) activity for the six months ended June 30, 2025 and 2024 (number of units and aggregate intrinsic value in thousands):
| Six Months Ended June 30,
| 2025 |  | 2024
| Number of Units |  | Weighted Average Grant-Date Fair Value |  | Number of Units |  | Weighted Average Grant-Date Fair Value
Units outstanding, beginning of year | 1,684 |  | $ | 356.31 |  |  | 1,615 |  |  | $ | 193.09 |
Granted | 44 |  | 565.42 |  |  | 551 |  | 263.77 |
Released | (328) |  | 282.89 |  |  | (279) |  |  | 194.31 |
Forfeited | (54) |  | 433.93 |  |  | (68) |  |  | 198.73 |
Units outstanding, end of period | 1,346 |  | 377.86 |  |  | 1,819 |  |  | 214.13 |
Aggregate intrinsic value at period-end | $ | 1,114,570 |  |  |  |  | $ | 535,066 |  |  |
Schedule of Performance Stock Unit Activity | The following table summarizes performance stock unit (“PSU”) activity, inclusive of XSUs, for the six months ended June 30, 2025 and 2024 (number of units and aggregate intrinsic value in thousands):
| Six Months Ended June 30,
| 2025 |  | 2024
| Number of Units |  | Weighted Average Grant-Date Fair Value |  | Number of Units |  | Weighted Average Grant-Date Fair Value
Units outstanding, beginning of year | 4,865 |  |  | $ | 261.18 |  |  | 394 |  |  | $ | 201.61 |
Granted | 73 |  |  | 481.91 |  |  | 4,517 |  |  | 240.07 |
Released | (526) |  |  | 293.79 |  |  | (11) |  |  | 149.49 |
Forfeited | (112) |  |  | 322.75 |  |  | (168) |  |  | 255.47 |
Units outstanding, end of period | 4,300 |  |  | 259.33 |  |  | 4,732 |  |  | 236.53 |
Aggregate intrinsic value at period-end | $ | 3,559,942 |  |  |  |  | $ | 1,392,469 |  |  |
Schedule of the Company's Stock Options Activity | The following table summarizes stock option activity for the six months ended June 30, 2025 and 2024 (number of units and aggregate intrinsic value in thousands):
| Six Months Ended June 30,
| 2025 |  | 2024
| Number of Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life (years) |  | Number of Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life (years)
Options outstanding, beginning of year | 21 |  | $ | 28.58 |  |  |  | 531 |  | $ | 28.58 |  |
Granted | — |  | — |  |  |  | — |  | — |  |
Exercised | — |  | — |  |  |  | — |  | — |  |
Expired / terminated | — |  | — |  |  |  | — |  | — |  |
Options outstanding and exercisable, end of period | 21 |  | $ | 28.58 |  | 2.66 |  | 531 |  | $ | 28.58 |  | 3.7
Aggregate intrinsic value at period-end | $ | 16,731 |  |  |  |  |  |  | $ | 141,047 |  |  |  |  |
Schedule of Reported Share-based Compensation | The following table summarizes the composition of stock-based compensation expense for the three and six months ended June 30, 2025 and 2024 (in thousands):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Cost of product and service sales | $ | 12,561 |  |  | $ | 8,517 |  |  | $ | 25,448 |  |  | $ | 38,112 |
Selling, general and administrative expenses | 72,187 |  |  | 38,633 |  |  | 143,534 |  |  | 61,788 |
Research and development expenses | 54,496 |  |  | 27,671 |  |  | 110,501 |  |  | 50,036 |
Total stock-based compensation expense | $ | 139,244 |  |  | $ | 74,821 |  |  | $ | 279,483 |  |  | $ | 149,936 |

X
- Definition Equity Compensation Goals [Table Text Block] + References No definition available. + Details
Name: | axon_EquityCompensationGoalsTableTextBlock
Namespace Prefix: | axon_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for performance stock units that were outstanding at the beginning and end of the year, and the number of performance stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | axon_ScheduleOfShareBasedCompensationPerformanceStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | axon_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration